Literature DB >> 24814970

A comparative study of conventional versus new, magnesium-poor Vacutainer® Sodium Citrate blood collection tubes for determination of prothrombin time and INR.

Anton M H P van den Besselaar1, Iris J H van Vlodrop2, Paul B Berendes2, Christa M Cobbaert3.   

Abstract

INTRODUCTION: Conventional Vacutainer® Sodium Citrate blood collection tubes contain a relatively high concentration of contaminating magnesium ions, which may result in shortening of the prothrombin time (PT) and the International Normalized Ratio (INR). Recently the manufacturer of Vacutainer® Sodium Citrate tubes introduced new tubes with a magnesium-poor stopper. The magnesium concentration in the new low-Mg tubes is significantly lower than that in the conventional plastic tubes. The purpose of the present study was to compare PT and INR determined in specimens drawn with the new tubes to those drawn with the conventional tubes.
MATERIALS AND METHODS: Venous blood specimens were collected from 22 healthy persons and 65 patients treated with vitamin K-antagonists using conventional Vacutainer® Sodium Citrate tubes and new, low-Mg Vacutainer® tubes. PT and INR were determined with four thromboplastin reagents, i.e., three brands of recombinant human tissue factor and one brand of combined rabbit brain reagent. Magnesium concentrations were determined in the citrate plasmas with a colorimetric method.
RESULTS: The differences in PT, INR and International Sensitivity Index (ISI) between the two tubes were significant when using three recombinant human thromboplastin reagents, but were not significant when using the rabbit thromboplastin. The PT and INR differences between the tubes correlated with the magnesium concentration differences (P<0.001). The INR bias between the four reagents was greater for specimens drawn with conventional tubes than the INR bias for specimens drawn with the new tubes.
CONCLUSION: Agreement of INR between reagents is improved by using magnesium-poor tubes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anticoagulant drugs; Blood specimen collection; Magnesium; Prothrombin Time; Therapeutic drug monitoring

Mesh:

Year:  2014        PMID: 24814970     DOI: 10.1016/j.thromres.2014.04.016

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Magnesium and Hemorrhage Volume in Patients With Aneurysmal Subarachnoid Hemorrhage.

Authors:  Eric M Liotta; Ameeta Karmarkar; Ayush Batra; Minjee Kim; Shyam Prabhakaran; Andrew M Naidech; Matthew B Maas
Journal:  Crit Care Med       Date:  2020-01       Impact factor: 7.598

2.  Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage.

Authors:  Eric M Liotta; Shyam Prabhakaran; Rajbeer S Sangha; Robin A Bush; Alan E Long; Stephen A Trevick; Matthew B Potts; Babak S Jahromi; Minjee Kim; Edward M Manno; Farzaneh A Sorond; Andrew M Naidech; Matthew B Maas
Journal:  Neurology       Date:  2017-07-26       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.